Drugs Made In America Acquisition II Corp.
- Close
- Jun 30, 2026
- Market cap
- —
- no share count on file
- Filings
- 47
—
—
—Q3 2026
—Q3 2026
——
—
——
—
—Q3 2026−98.7% FY25 yoy
Price
Jun 30, 2026 · 13F quarter end
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
General And Administrative
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $488,385 | reported |
Blank check companies
Drugs Made In America Acquisition II Corp. is the largest of the 307 covered companies the SEC files under this code, by market cap. SIC 6770
CompanyRevenueGrowthNet marginMarket cap
DMIIRDrugs Made In America Acquisition II Corp. (this company)———$651.0M
EVACEQV Ventures Acquisition Corp. II———$605.8MBCSSBain Capital GSS Investment Corp.———$600.9MCEPFCantor Equity Partners IV, Inc.———$595.5MCXIIChurchill Capital Corp XII———$575.8MAEXAAmerican Exceptionalism Acquisition Corp. A———$532.7MNWAXNew America Acquisition I Corp.———$500.5MAACAres Acquisition Corp III———$497.2MMLAAMountain Lake Acquisition Corp. II———$491.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Drugs Made In America Acquisition II Corp. · CIK 2040475 · Engraved from SEC EDGAR